11212017Headline:

Galveston Bay, Texas

HomeTexasGalveston Bay

Email Allison Snoddy Allison Snoddy on LinkedIn Allison Snoddy on Twitter Allison Snoddy on Facebook
Allison Snoddy
Allison Snoddy
Contributor •

Paxil.

Comments Off

The Food and Drug Administration today is alerting health care professionals and patients about early results of new studies for Paxil (paroxetine) suggesting that the drug increases the risk for birth defects, particularly heart defects, when women take it during the first three months of pregnancy. Paxil is approved for the treatment of depression and several other psychiatric disorders. FDA is currently gathering additional data and waiting for the final results of the recent studies in order to better understand the higher risk for birth defects that has been seen with Paxil.

FDA is advising patients that this drug should usually not be taken during pregnancy, but for some women who have already been taking Paxil, the benefits of continuing may be greater than the potential risk to the fetus. Women taking Paxil who are pregnant or plan to become pregnant should talk to their physicians about the potential risks of taking the drug during pregnancy. Women taking Paxil should not stop taking it without first talking with their physician. If you or a loved one has taken Paxil, please contact us today. We can help.

For more information on this subject matter, please refer to the section on Drugs, Medical Devices, & Implants.